Pulmonary nodule
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years, no gender limit; 2. Patients diagnosed with peripheral pulmonary nodule require biopsy; 3. Patients agree to receive bronchoscopic procedure and meet the requirements of bronchoscopy; 4. Patients who can understand the objectives of study, have good compliance with the tests and follow-up, agree to participate in the clinical trial and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Female patients who are breastfeeding or pregnant or preparing for pregnancy; 2. Patients with electromagnetic active implants in their bodies; 3. The patient is allergic to anesthetic; Or have multiple history of severe allergies, genetic allergies; 4. Participated in or is participating in clinical trials of drugs within 3 months prior to screening, or participated in clinical trials of other medical devices within 30 days prior to screening; 5. Other conditions deemed unsuitable for participation in this clinical trial by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic yield; | — |
Secondary
| Measure | Time frame |
|---|---|
| The successful reach rate of bronchoscope navigation control system and catheter;The detection rate of bronchoscope navigation control system and catheter;Performance evaluation of the medical device ; | — |
Countries
China
Contacts
The First Hospital of Guangzhou Medical University